Quotient Sciences Recognized as a Winner of 2025 CDMO Leadership Awards
Read More61 - 65 of 154 results
Quotient Sciences, a leading global pharmaceutical drug development and manufacturing accelerator, is proud to announce the successful completion of a US Food and Drug Administration (FDA) inspection of its bioanalytical facility in Alnwick...
Learn more
Nick McEntee, Executive Director, Head of UK GMP Operations at Quotient Sciences discusses strategies for flexible, on-demand manufacture of clinical trial materials (CTMs) with Contract Pharma.Clinical trials are a critical component in dr...
Learn more
What are the "3 Key Trends" that are shaping the CDMO industry in 2023 and beyond?From integrated drug development services to sterile drug manufacturing, our Executive Director of Commercial, Dr. Eleanor Row, touches on it all in...
Learn more
Oxilio completes Phase 1 clinical trial with OXL001 at Quotient Sciences - Nottingham with favorable safety and pharmacokinetic data. Also announced, the commencement of an additional pre-clinical program that will enhance understanding of ...
Learn more
In June 2023, Chris Roe and Ricardo Diaz de Leon Ortega presented at the Basic Biopharmaceutics Workshop in London, focusing on biopharmaceutics principles for oral drug product development.
Learn more
